期刊文献+

定量RT-PCR测定食管鳞癌组织中人叉头样转录因子3基因的表达 被引量:3

Measurement of the Forkhead Box P3 Gene Expression Levels in Esophageal Squamous Cell Carcinoma by Real-time Quantitative Reverse Transcription-polymerase Chain Reaction
下载PDF
导出
摘要 目的测定食管鳞状细胞癌组织中人叉头样转录因子3(forkhead box P3,FOXP3)的基因表达水平,为食管癌的免疫治疗提供依据。方法基于TaqMan荧光探针技术,构建克隆载体pMD 18-T-FOXP3,作为定量模板,建立检测FOXP3信使核糖核酸(mRNA)含量的实时荧光定量逆转录-聚合酶链反应(RT-PCR)方法,在GeneAmp7500型检测仪上测定42例食管鳞癌组织和30例正常对照组织中FOXP3 mRNA的含量。结果食管鳞癌组织FOXP3 mRNA表达高于正常对照组织[(72.20±23.10)×104拷贝/μg RNA vs.(0.68±0.34)×104拷贝/μg RNA;P<0.05]。结论成功建立了人FOXP3基因mRNA表达含量的荧光定量检测方法,FOXP3在食管鳞癌组织中的表达较正常对照组织增高。 Objective To detect the expression of forkhead box P3 (FOXP3)gene in esophageal squamous cell carcinoma(ESCC) and provide a new basis for immunotherapy of esophageal cancer. Methods Based on fluorescent TaqMan methodology, a real-time quantitative reverse transcription-polymerase chain reaction (RT-PCR) for detecting the expression of FOXP3 was set up. In this method, a cloning vector DMD 18-T-FOXP3 was constructed as a standard plasmid. The specific expression of FOXP3 in 42 patients with ESCC and 30 healthy controls were measured by using GeneAmp 7500 Sequence Detection Systems. Results FOXP3 mRNA copy number in ESCC was significantly higher than that in healthy control tissue [(72.20±23.10) × 10^4copy/μg RNA vs. (0.68±0.34) × 10^4copy/μg RNA;P〈0.05]. Conclusion A real-time quantitative RT-PCR method for detecting the expression of FOXP3 gene in ESCC has been successfully established. The expression level of FOXP3 is increased in ESCC compare with healthy controls.
出处 《中国胸心血管外科临床杂志》 CAS 2009年第3期206-209,共4页 Chinese Journal of Clinical Thoracic and Cardiovascular Surgery
关键词 食管鳞状细胞癌 叉头样转录因子3 实时荧光定量逆转录聚合酶链反应 克隆载体 Esophageal squamous cell carcinoma Forkhead box P3 Reverse transcription-polymerase chain reaction Cloning vector
  • 相关文献

参考文献14

  • 1Brunkow ME, Jeffery EW, Hjerrild KA, et al. Disruption of a new forkhead/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse. Nat Genet, 2001,27( 1 ): 68-73.
  • 2Hori S, Nomura T, Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3. Science, 2003, 299(5609) :1057-1061.
  • 3Gallimore A, Godkin A. Regulatory T cells and tumour immunity observations in mice and men. Immunology, 2008,123 (2) : 157-163.
  • 4Kono K, Kawaida H, Takahashi A, et al. CD4(+)CD25high regulatory T cells increase with tumor stage in patients with gastric and esophageal cancers. Cancer Immunol Immunother, 2006,55 (9) : 1064-1071.
  • 5Holland PM, Abramson RD, Watson R, et al. Detection of specific polymerase chain reaction product by utilizing the 5'- 3' exonuclease activity of thermus aquaticus DNA polymerase. Proc Natl Acad Sci USA, 1991,88(16):7276-7280-
  • 6Ginlietti A, Overbergh L, Valckx D, et al. An overview of realtime quantitative PCR: applications to quantify cytokine gene expression. Methods, 2001,25(4):386 -401.
  • 7庄翔,刘伦旭,朱文,陈利华,宋煜宏,任光国,李强,韩泳涛.肺癌患者外周血中Lunx mRNA的检测及其临床意义[J].中国胸心血管外科临床杂志,2007,14(3):184-187. 被引量:15
  • 8李东亮,王如文,蒋耀光,谭群友,龚太乾.肺减容术对肺气肿兔膈肌骨架蛋白mRNA表达的影响[J].中国胸心血管外科临床杂志,2006,13(4):251-254. 被引量:1
  • 9Lu S, Wang TD. In vivo cancer biomarkers of esophageal neoplasia. Cancer Biomark, 2008,4(6) :341-350.
  • 10Xu XC. Risk factors and gene expression in esophageal cancer. Methods Mol Biol. United States: Humana Press, 2009. 335-360.

二级参考文献22

共引文献14

同被引文献22

  • 1Ke X, Wang J, Li L, et al. Roles of CD4+CD25(high) FOXP3+ Tregs in lymphomas and tumors are complex[J]. Front Biosci, 2008, 13: 3986- 4001.
  • 2Douglas C, Wu Joanna, Hester Satish N, et al. Ex vivo expanded human regulatory T cells can prolong survival of a human islet allograft in a humanized mouse model [J]. Wood Transplantation, 2013, 96(8): 707-716.
  • 3Harald, von Boehmer Carolin, Daniel. Therapeutic opportunities for manipulating T (Reg) cells in autoimmunity and cancer [J]. Nature reviews Drug discovery, 2013, 12(1): 51-63.
  • 4Helena S, Veronica O, Samuel L. Accumulation of CCR4+ CTLA-4hi Foxp3+CD25hi regulatory T cells in colon adenoearcinomas correlate to reduced activation of conventional T cells [J]. PLoS One, 2012, (02): 30695-30699.
  • 5Liu X, Xu X, Lin X. PTD-hFOXP3 protein acts as an immune regulator to convert human CD4+ CD25-T cells to regulatory T-like cells[J]. Journal of Cellular Biochemistry, 2012, (12): 3797-3809.
  • 6Ohkura N, Hamaguchi M, Morikawa H. T cell receptor stimulation-induced epigenetic changes and foxp3 expression are independent and complementary events required for treg cell development[J]. Immunity, 2012, (05): 785-799.
  • 7Afonso J, Longatto-Filho A, Martinho O, et al. Low RKIP expression associates with poor prognosis in bladder cancer patients[J]. Virchows Arch, 2013, 462(4): 445-453.
  • 8Zuo T, Liu R, Zhang H, et al. FOXP3 is a novel transcriptional repressor for the breast cancer oncogene SKP2[J]. J Clin Invest, 2007 ,117(12): 3765-3773.
  • 9Zuo T, Wang L, Morrison C, et al. FOXP3 is an X-linked breast cancer suppressor gene and an important repressor of the HER-2/ ErbB2 oncogene[J]. Cell, 2007, 129(7): 1275-1286.
  • 10Hinz S, Pagerols-Raluy L, Oberg HH, et al. Foxp3 expression in pancreatic carcinoma ceils as a novel mechanism of immune evasion in cancer[J]. Cancer Res, 2007, 67(17): 8344-8350.

引证文献3

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部